Shaline Rao. Adv Ther 2022
Times Cited: 3
Times Cited: 3
Times Cited
Times Co-cited
Similarity
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Theresa A McDonagh, Marco Metra, Marianna Adamo, Roy S Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel,[...]. Eur Heart J 2021
Theresa A McDonagh, Marco Metra, Marianna Adamo, Roy S Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel,[...]. Eur Heart J 2021
66
Short commentary on empagliflozin and its potential clinical impact.
Deborah Hinnen. Ther Adv Endocrinol Metab 2015
Deborah Hinnen. Ther Adv Endocrinol Metab 2015
33
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease.
Kohei Kaku, Christoph Wanner, Stefan D Anker, Stuart Pocock, Atsutaka Yasui, Michaela Mattheus, Søren S Lund. Diabetes Obes Metab 2022
Kohei Kaku, Christoph Wanner, Stefan D Anker, Stuart Pocock, Atsutaka Yasui, Michaela Mattheus, Søren S Lund. Diabetes Obes Metab 2022
33
Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials.
Huilin Tang, Xi Zhang, Jingjing Zhang, Yufeng Li, Liana C Del Gobbo, Suodi Zhai, Yiqing Song. Diabetologia 2016
Huilin Tang, Xi Zhang, Jingjing Zhang, Yufeng Li, Liana C Del Gobbo, Suodi Zhai, Yiqing Song. Diabetologia 2016
33
Management of Dehydration in Patients Suffering Swallowing Difficulties.
Emilie Reber, Filomena Gomes, Ilka A Dähn, Maria F Vasiloglou, Zeno Stanga. J Clin Med 2019
Emilie Reber, Filomena Gomes, Ilka A Dähn, Maria F Vasiloglou, Zeno Stanga. J Clin Med 2019
33
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.
Michael Roden, Jianping Weng, Jens Eilbracht, Bruno Delafont, Gabriel Kim, Hans J Woerle, Uli C Broedl. Lancet Diabetes Endocrinol 2013
Michael Roden, Jianping Weng, Jens Eilbracht, Bruno Delafont, Gabriel Kim, Hans J Woerle, Uli C Broedl. Lancet Diabetes Endocrinol 2013
33
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
Stefan D Anker, Javed Butler, Gerasimos Filippatos, João P Ferreira, Edimar Bocchi, Michael Böhm, Hans-Peter Brunner-La Rocca, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure-Valenzuela,[...]. N Engl J Med 2021
Stefan D Anker, Javed Butler, Gerasimos Filippatos, João P Ferreira, Edimar Bocchi, Michael Böhm, Hans-Peter Brunner-La Rocca, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure-Valenzuela,[...]. N Engl J Med 2021
33
Severe Hypernatraemic Dehydration and Unconsciousness in a Care-Dependent Inpatient Treated with Empagliflozin.
Georg Gelbenegger, Nina Buchtele, Christian Schoergenhofer, Martin Roeggla, Michael Schwameis. Drug Saf Case Rep 2017
Georg Gelbenegger, Nina Buchtele, Christian Schoergenhofer, Martin Roeggla, Michael Schwameis. Drug Saf Case Rep 2017
33
33
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.
Hans-Ulrich Häring, Ludwig Merker, Elke Seewaldt-Becker, Marc Weimer, Thomas Meinicke, Uli C Broedl, Hans J Woerle. Diabetes Care 2014
Hans-Ulrich Häring, Ludwig Merker, Elke Seewaldt-Becker, Marc Weimer, Thomas Meinicke, Uli C Broedl, Hans J Woerle. Diabetes Care 2014
33
Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes Mellitus.
Masaki Nakagaito, Shuji Joho, Ryuichi Ushijima, Makiko Nakamura, Koichiro Kinugawa. Circ Rep 2019
Masaki Nakagaito, Shuji Joho, Ryuichi Ushijima, Makiko Nakamura, Koichiro Kinugawa. Circ Rep 2019
33
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.
Donald E Kohan, Paola Fioretto, Weihua Tang, James F List. Kidney Int 2014
Donald E Kohan, Paola Fioretto, Weihua Tang, James F List. Kidney Int 2014
33
Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor.
Robert Allison, Daniel Goldstein, Mandi W Musso. J Emerg Med 2019
Robert Allison, Daniel Goldstein, Mandi W Musso. J Emerg Med 2019
33
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial.
Stefan D Anker, Javed Butler, Gerasimos Filippatos, Muhammad Shahzeb Khan, Nikolaus Marx, Carolyn S P Lam, Sven Schnaidt, Anne Pernille Ofstad, Martina Brueckmann, Waheed Jamal,[...]. Circulation 2021
Stefan D Anker, Javed Butler, Gerasimos Filippatos, Muhammad Shahzeb Khan, Nikolaus Marx, Carolyn S P Lam, Sven Schnaidt, Anne Pernille Ofstad, Martina Brueckmann, Waheed Jamal,[...]. Circulation 2021
33
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study.
Mikhail Kosiborod, Kåre I Birkeland, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Marit E Jørgensen, Eric T Wittbrodt,[...]. Diabetes Obes Metab 2018
Mikhail Kosiborod, Kåre I Birkeland, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Marit E Jørgensen, Eric T Wittbrodt,[...]. Diabetes Obes Metab 2018
33
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure.
Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, Yasuki Kihara, Koichiro Kinugawa, Shintaro Kinugawa, Miyuki Makaya, Toyoaki Murohara, Koichi Node, Yoshihiko Saito,[...]. Circ J 2021
Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, Yasuki Kihara, Koichiro Kinugawa, Shintaro Kinugawa, Miyuki Makaya, Toyoaki Murohara, Koichi Node, Yoshihiko Saito,[...]. Circ J 2021
33
Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia.
J B Dossetor. Ann Intern Med 1966
J B Dossetor. Ann Intern Med 1966
33
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.
Christoph Wanner, John M Lachin, Silvio E Inzucchi, David Fitchett, Michaela Mattheus, Jyothis George, Hans J Woerle, Uli C Broedl, Maximilian von Eynatten, Bernard Zinman. Circulation 2018
Christoph Wanner, John M Lachin, Silvio E Inzucchi, David Fitchett, Michaela Mattheus, Jyothis George, Hans J Woerle, Uli C Broedl, Maximilian von Eynatten, Bernard Zinman. Circulation 2018
33
Effects of SGLT2 Inhibitors on Renal Outcomes in Patients With Chronic Kidney Disease: A Meta-Analysis.
Ning Li, Dan Lv, Xiangjun Zhu, Ping Wei, Yuan Gui, Shijia Liu, Enchao Zhou, Min Zheng, Dong Zhou, Lu Zhang. Front Med (Lausanne) 2021
Ning Li, Dan Lv, Xiangjun Zhu, Ping Wei, Yuan Gui, Shijia Liu, Enchao Zhou, Min Zheng, Dong Zhou, Lu Zhang. Front Med (Lausanne) 2021
33
Clinical indicators of dehydration severity in elderly patients.
C R Gross, R D Lindquist, A C Woolley, R Granieri, K Allard, B Webster. J Emerg Med 1992
C R Gross, R D Lindquist, A C Woolley, R Granieri, K Allard, B Webster. J Emerg Med 1992
33
Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus.
Christopher S Kovacs, Veeraswamy Seshiah, Ludwig Merker, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Peter Stella, Hans-Juergen Woerle, Uli C Broedl. Clin Ther 2015
Christopher S Kovacs, Veeraswamy Seshiah, Ludwig Merker, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Peter Stella, Hans-Juergen Woerle, Uli C Broedl. Clin Ther 2015
33
Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin.
Ralph A DeFronzo, Andrew Lewin, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J Woerle, Uli C Broedl. Diabetes Care 2015
Ralph A DeFronzo, Andrew Lewin, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J Woerle, Uli C Broedl. Diabetes Care 2015
33
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, Kenneth Mangion, Giles Roditi, Ross T Campbell, Colin Berry, Victor Chong, Liz Coyle, Kieran F Docherty,[...]. Circulation 2021
Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, Kenneth Mangion, Giles Roditi, Ross T Campbell, Colin Berry, Victor Chong, Liz Coyle, Kieran F Docherty,[...]. Circulation 2021
33
ESPEN guideline on clinical nutrition and hydration in geriatrics.
Dorothee Volkert, Anne Marie Beck, Tommy Cederholm, Alfonso Cruz-Jentoft, Sabine Goisser, Lee Hooper, Eva Kiesswetter, Marcello Maggio, Agathe Raynaud-Simon, Cornel C Sieber,[...]. Clin Nutr 2019
Dorothee Volkert, Anne Marie Beck, Tommy Cederholm, Alfonso Cruz-Jentoft, Sabine Goisser, Lee Hooper, Eva Kiesswetter, Marcello Maggio, Agathe Raynaud-Simon, Cornel C Sieber,[...]. Clin Nutr 2019
33
Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.
Hans-Ulrich Häring, Ludwig Merker, Elke Seewaldt-Becker, Marc Weimer, Thomas Meinicke, Hans J Woerle, Uli C Broedl. Diabetes Care 2013
Hans-Ulrich Häring, Ludwig Merker, Elke Seewaldt-Becker, Marc Weimer, Thomas Meinicke, Hans J Woerle, Uli C Broedl. Diabetes Care 2013
33
Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension.
Ilkka Tikkanen, Kirsi Narko, Cordula Zeller, Alexandra Green, Afshin Salsali, Uli C Broedl, Hans J Woerle. Diabetes Care 2015
Ilkka Tikkanen, Kirsi Narko, Cordula Zeller, Alexandra Green, Afshin Salsali, Uli C Broedl, Hans J Woerle. Diabetes Care 2015
33
Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes.
Andrew Lewin, Ralph A DeFronzo, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J Woerle, Uli C Broedl. Diabetes Care 2015
Andrew Lewin, Ralph A DeFronzo, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J Woerle, Uli C Broedl. Diabetes Care 2015
33
Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.
R Grempler, L Thomas, M Eckhardt, F Himmelsbach, A Sauer, D E Sharp, R A Bakker, M Mark, T Klein, P Eickelmann. Diabetes Obes Metab 2012
R Grempler, L Thomas, M Eckhardt, F Himmelsbach, A Sauer, D E Sharp, R A Bakker, M Mark, T Klein, P Eickelmann. Diabetes Obes Metab 2012
33
Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.
Matthew Griffin, Veena S Rao, Juan Ivey-Miranda, James Fleming, Devin Mahoney, Christopher Maulion, Nisha Suda, Krishmita Siwakoti, Tariq Ahmad, Daniel Jacoby,[...]. Circulation 2020
Matthew Griffin, Veena S Rao, Juan Ivey-Miranda, James Fleming, Devin Mahoney, Christopher Maulion, Nisha Suda, Krishmita Siwakoti, Tariq Ahmad, Daniel Jacoby,[...]. Circulation 2020
33
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.
Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C Broedl, Hans-Juergen Woerle. J Clin Invest 2014
Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C Broedl, Hans-Juergen Woerle. J Clin Invest 2014
33
A new equation to estimate glomerular filtration rate.
Andrew S Levey, Lesley A Stevens, Christopher H Schmid, Yaping Lucy Zhang, Alejandro F Castro, Harold I Feldman, John W Kusek, Paul Eggers, Frederick Van Lente, Tom Greene,[...]. Ann Intern Med 2009
Andrew S Levey, Lesley A Stevens, Christopher H Schmid, Yaping Lucy Zhang, Alejandro F Castro, Harold I Feldman, John W Kusek, Paul Eggers, Frederick Van Lente, Tom Greene,[...]. Ann Intern Med 2009
33
Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
Hélène Nougué, Théo Pezel, François Picard, Malha Sadoune, Mattia Arrigo, Florence Beauvais, Jean-Marie Launay, Alain Cohen-Solal, Nicolas Vodovar, Damien Logeart. Eur J Heart Fail 2019
Hélène Nougué, Théo Pezel, François Picard, Malha Sadoune, Mattia Arrigo, Florence Beauvais, Jean-Marie Launay, Alain Cohen-Solal, Nicolas Vodovar, Damien Logeart. Eur J Heart Fail 2019
33
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients.
Peter Winkle, Steven Goldsmith, Michael J Koren, Serge Lepage, Jennifer Hellawell, Ashit Trivedi, Kate Tsirtsonis, Siddique A Abbasi, Allegra Kaufman, Richard Troughton,[...]. Cardiovasc Drugs Ther 2022
Peter Winkle, Steven Goldsmith, Michael J Koren, Serge Lepage, Jennifer Hellawell, Ashit Trivedi, Kate Tsirtsonis, Siddique A Abbasi, Allegra Kaufman, Richard Troughton,[...]. Cardiovasc Drugs Ther 2022
50
Increased plasma level of apelin with NYHA grade II and III but not IV.
Ling Han, Bingzhang Jie, Jingguang Luo, Liwei Chen, Ye Jia, Like Guo, Yan Zhao, Xin Chen, Xiaogang Zhu, Xu Teng,[...]. Amino Acids 2020
Ling Han, Bingzhang Jie, Jingguang Luo, Liwei Chen, Ye Jia, Like Guo, Yan Zhao, Xin Chen, Xiaogang Zhu, Xu Teng,[...]. Amino Acids 2020
100
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis.
Tayler A Buchan, Crizza Ching, Farid Foroutan, Abdullah Malik, Julian F Daza, Nicholas Ng Fat Hing, Reed Siemieniuk, Nathan Evaniew, Ani Orchanian-Cheff, Heather J Ross,[...]. Heart Fail Rev 2022
Tayler A Buchan, Crizza Ching, Farid Foroutan, Abdullah Malik, Julian F Daza, Nicholas Ng Fat Hing, Reed Siemieniuk, Nathan Evaniew, Ani Orchanian-Cheff, Heather J Ross,[...]. Heart Fail Rev 2022
33
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Joao Pedro Ferreira, Stuart J Pocock, Naveed Sattar, Martina Brueckmann, Waheed Jamal, Daniel Cotton,[...]. J Am Coll Cardiol 2021
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Joao Pedro Ferreira, Stuart J Pocock, Naveed Sattar, Martina Brueckmann, Waheed Jamal, Daniel Cotton,[...]. J Am Coll Cardiol 2021
33
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
33
Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis.
Nan Zhang, Yueying Wang, Gary Tse, Panagiotis Korantzopoulos, Konstantinos P Letsas, Qingpeng Zhang, Guangping Li, Gregory Y H Lip, Tong Liu. Eur J Prev Cardiol 2022
Nan Zhang, Yueying Wang, Gary Tse, Panagiotis Korantzopoulos, Konstantinos P Letsas, Qingpeng Zhang, Guangping Li, Gregory Y H Lip, Tong Liu. Eur J Prev Cardiol 2022
33
Effect of Spironolactone on Plasma Apelin-12 Levels in Patients with Chronic Systolic Heart Failure.
Mustafa Topuz, Mehmet Cosgun, Oğuz Akkuş, Atilla Bulut, Omer Sen, Ayşe Nur Topuz, Murat Caylı. Acta Cardiol Sin 2016
Mustafa Topuz, Mehmet Cosgun, Oğuz Akkuş, Atilla Bulut, Omer Sen, Ayşe Nur Topuz, Murat Caylı. Acta Cardiol Sin 2016
33
Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes.
Robert J Chilton. Diabetes Obes Metab 2020
Robert J Chilton. Diabetes Obes Metab 2020
33
Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Serum Electrolyte Levels in Patients with Type 2 Diabetes: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials.
Jingjing Zhang, Yonghong Huan, Mark Leibensperger, Bojung Seo, Yiqing Song. Kidney360 2022
Jingjing Zhang, Yonghong Huan, Mark Leibensperger, Bojung Seo, Yiqing Song. Kidney360 2022
33
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
Peder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, Milton Packer, Akshay S Desai, Jean L Rouleau, Michael R Zile, Karl Swedberg, Martin Lefkowitz, Victor Shi,[...]. J Am Coll Cardiol 2019
Peder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, Milton Packer, Akshay S Desai, Jean L Rouleau, Michael R Zile, Karl Swedberg, Martin Lefkowitz, Victor Shi,[...]. J Am Coll Cardiol 2019
33
Natriuretic Peptides and Risk of Type 2 Diabetes: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
Chaterina Sujana, Veikko Salomaa, Frank Kee, Simona Costanzo, Stefan Söderberg, Jens Jordan, Pekka Jousilahti, Charlotte Neville, Licia Iacoviello, Viktor Oskarsson,[...]. Diabetes Care 2021
Chaterina Sujana, Veikko Salomaa, Frank Kee, Simona Costanzo, Stefan Söderberg, Jens Jordan, Pekka Jousilahti, Charlotte Neville, Licia Iacoviello, Viktor Oskarsson,[...]. Diabetes Care 2021
100
Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review.
Ana C Alba, Thomas Agoritsas, Milosz Jankowski, Delphine Courvoisier, Stephen D Walter, Gordon H Guyatt, Heather J Ross. Circ Heart Fail 2013
Ana C Alba, Thomas Agoritsas, Milosz Jankowski, Delphine Courvoisier, Stephen D Walter, Gordon H Guyatt, Heather J Ross. Circ Heart Fail 2013
33
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update.
Shannon M Dunlay, Michael M Givertz, David Aguilar, Larry A Allen, Michael Chan, Akshay S Desai, Anita Deswal, Victoria Vaughan Dickson, Mikhail N Kosiborod, Carolyn L Lekavich,[...]. Circulation 2019
Shannon M Dunlay, Michael M Givertz, David Aguilar, Larry A Allen, Michael Chan, Akshay S Desai, Anita Deswal, Victoria Vaughan Dickson, Mikhail N Kosiborod, Carolyn L Lekavich,[...]. Circulation 2019
33
The Apelin-APJ System in the Evolution of Heart Failure.
Cerasela Mihaela Goidescu, Luminiţa Animarie Vida-Simiti. Clujul Med 2015
Cerasela Mihaela Goidescu, Luminiţa Animarie Vida-Simiti. Clujul Med 2015
33
Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update.
Ethan S Palmer, Nigel Irwin, Finbarr Pm O'Harte. Clin Med Insights Endocrinol Diabetes 2022
Ethan S Palmer, Nigel Irwin, Finbarr Pm O'Harte. Clin Med Insights Endocrinol Diabetes 2022
50
Comparative Cardiovascular Outcomes of SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Controlled Trials.
Yu Jiang, Pingping Yang, Linghua Fu, Lizhe Sun, Wen Shen, Qinghua Wu. Front Endocrinol (Lausanne) 2022
Yu Jiang, Pingping Yang, Linghua Fu, Lizhe Sun, Wen Shen, Qinghua Wu. Front Endocrinol (Lausanne) 2022
33
The therapeutic potentials of apelin in obesity-associated diseases.
I Castan-Laurell, C Dray, P Valet. Mol Cell Endocrinol 2021
I Castan-Laurell, C Dray, P Valet. Mol Cell Endocrinol 2021
33
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.